Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Neoplasm Proteins. Found 47 abstracts

no pagination
Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clinical advances in hematology & oncology : H&O. 2018 Oct;16(10):677-86.
Michael JV, Wurtzel JG, Mao GF, Rao AK, Kolpakov MA, Sabri A, Hoffman NE, Rajan S, Tomar D, Madesh M, Nieman MT, Yu J, Edelstein LC, Rowley JW, Weyrich AS, Goldfinger LE. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth. Blood. 2017 Aug 03;130(5):567-80.   PMCID: PMC5542851
Troupes CD, Wallner M, Borghetti G, Zhang C, Mohsin S, von Lewinski D, Berretta RM, Kubo H, Chen X, Soboloff J, Houser S. Role of STIM1 (Stromal Interaction Molecule 1) in Hypertrophy-Related Contractile Dysfunction. Circulation research. 2017 Jul 07;121(2):125-36.   PMCID: PMC5531450
Dasgupta Y, Koptyra M, Hoser G, Kantekure K, Roy D, Gornicka B, Nieborowska-Skorska M, Bolton-Gillespie E, Cerny-Reiterer S, Muschen M, Valent P, Wasik MA, Richardson C, Hantschel O, van der Kuip H, Stoklosa T, Skorski T. Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases. Blood. 2016 Apr 28;127(17):2131-43.   PMCID: PMC4850868
Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar AK, Garden AS, Soulieres D, Trotti A, Avizonis VN, Ridge JA, Harris J, Le QT, Gillison M. Reply to B. O'Sullivan et Al. J Clin Oncol. 2015 May 20;33(15):1708-9.
Hochster HS, Uboha N, Messersmith W, Gold PJ, O Neil BH, Cohen D, Denlinger C, Cohen S, Leichman CG, Leichman L, Lenz HJ. Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan;75(1):17-23.
Hooper R, Zhang X, Webster M, Go C, Kedra J, Marchbank K, Gill DL, Weeraratna AT, Trebak M, Soboloff J. Novel Protein Kinase C-Mediated Control of Orai1 Function in Invasive Melanoma. Mol Cell Biol. 2015 Aug;35(16):2790-8.   PMCID: 4508319
Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. 2014 Aug 21;124(8):1259-65.   PMCID: Pmc4141515
Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head & neck. 2014 Dec;36(12):1677-84.   PMCID: PMC3972378
Sodani K, Patel A, Anreddy N, Singh S, Yang DH, Kathawala RJ, Kumar P, Talele TT, Chen ZS. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochemical pharmacology. 2014 May;89(1):52-61.   PMCID: Pmc3983711
Cheung M, Testa JR. Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets. 2013 Mar;13(3):234-44.   PMCID: PMC3678724
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. J Gastrointest Cancer. 2013 Dec;44(4):450-5.   PMCID: Pmc3963822
Patel BB, Li XM, Dixon MP, Blagoi EL, Nicolas E, Seeholzer SH, Cheng D, He YA, Coudry RA, Howard SD, Riddle DM, Cooper HC, Boman BM, Conrad P, Crowell JA, Bellacosa A, Knudson A, Yeung AT, Kopelovich L. APC +/- alters colonic fibroblast proteome in FAP. Oncotarget. 2011 Mar;2(3):197-208.   PMCID: PMC3195363
Ding Y, Larson G, Rivas G, Lundberg C, Geller L, Ouyang C, Weitzel J, Archambeau J, Slater J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Nordborg M, Krontiris TG. Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk. PLoS ONE. 2008 Jan;3(10):e3533.   PMCID: PMC2568805
Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. The Prostate. 2007 May;67(6):582-90.
Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol. 2007 Mar;27(6):2343-58.
Hartman TR, Qian S, Bolinger C, Fernandez S, Schoenberg DR, Boris-Lawrie K. RNA helicase A is necessary for translation of selected messenger RNAs. Nature structural & molecular biology. 2006 May 07;13(6):509-16.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30.
Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A, Cairns P. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clinical Cancer Research. 2004 Jan;10(1, Pt. 1):28-32.
Langer CJ. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC. Int J Radiat Oncol Biol Phys. 2004 Mar;58(3):991-1002.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Neoplasm Proteins

Neoplasm Proteins metabolism genetics Male pathology Female drug therapy Antineoplastic Agents Aged Adult therapeutic use Middle Aged Mice antagonists & inhibitors Biological Tumor Markers physiology Case-Control Studies Tumor Cell Line biosynthesis Mutation Neoplasm Invasiveness Oxidative Stress Neoplastic Gene Expression Regulation Squamous Cell Carcinoma Non-Histone Chromosomal Proteins Proto-Oncogene Proteins Comparative Study mortality Survival Analysis Lung Neoplasms Cell Cycle Proteins Heterochromatin Cell Aging Papillomavirus Infections Human Neoplasm Metastasis adverse effects Cell Line Neoplasm Drug Resistance Pyridazines Prostatic Neoplasms Protein Kinase Inhibitors 80 and over Aged isolation & purification Papillomaviridae Histones ras Proteins me [Metabolism] administration & dosage 0 (Neoplasm Proteins) Transcription Factors Cell Cycle drug effects virology Survival Rate Molecular Sequence Data Amino Acid Sequence Drug Dose-Response Relationship Tumor Suppressor Proteins Repressor Proteins pa [Pathology] Down-Regulation Needle Biopsy 0 (Cell Cycle Proteins) Colorectal Neoplasms Tyrosine kinase inhibitor Proteinase-Activated Receptors 0 (Transcription Factor AP-1) agonists 0 (Histones) Proto-Oncogene Proteins c-akt Phenotype derivatives NADH Dehydrogenase Apoptosis MicroRNAs pd [Pharmacology] Introns Selection (Genetics) Biological) 0 (Tumor Markers 17407-37-3 (vitamin E succinate) HIV Seropositivity 0 (NF-kappa B) SCID Mice B-Cell Lymphoma Telatinib Anus Neoplasms Acid Anhydride Hydrolases Clear Cell Adenocarcinoma Neoplastic Stem Cells Proto-Oncogene Proteins c-abl Nuclear Proteins an [Analysis] Ca (2+)-Calmodulin Dependent Protein Kinase Angiogenesis Inhibitors Experimental Leukemia Enzyme Activation Melanoma Cell-Derived Microparticles 0 (Nuclear Proteins) 0 (Repressor Proteins) Immunoenzyme Techniques DNA Methylation Body Fluids Protein Kinase C Vascular Endothelial Growth Factor A Age Factors Oropharyngeal Neoplasms Western Blotting Transcription Factor AP-1 Gene Expression Profiling calcium Camptothecin Vitamin E Intracellular Signaling Peptides and Proteins Cisplatin Fibroblasts Recombinant Fusion Proteins aa [Analogs & Derivatives] Molecular Models Cardiomegaly Non-US Gov't Research Support Breast Neoplasms NF-kappa B Superoxide Dismutase Protein Biosynthesis Local Neoplasm Recurrence Clinical Trials Dosage Compensation (Genetics) 0 (macroH2A histone) Conserved Sequence transplantation human papillomavirus (HPV) Non-Small-Cell Lung Carcinoma cy [Cytology] protein HP-1) use Immunohistochemistry ai [Antagonists & Inhibitors] Animal Disease Models Cell Adhesion Young Adult Nude Mice Intraductal Carcinoma-Noninfiltrating Follow-Up Studies Biological Models therapy DEAD-box RNA Helicases Imidazoles Viral DNA
Last updated on Friday, January 03, 2020